Samjin Pharm (005500) — Cash Flow Reinvestment Rate
Samjin Pharm (005500) has a Cash Flow Reinvestment Rate of 0.93x as of June 2025, reinvesting ₩9.90 Billion (capex ₩3.78 Billion plus investments ₩-6.12 Billion) from operating cash flow of ₩10.63 Billion. Explore capital reinvestment ratio of Samjin Pharm to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Samjin Pharm Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Samjin Pharm across 12 annual periods. Also explore Samjin Pharm total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Samjin Pharm (2013–2024)
Year-by-year capital reinvestment analysis for Samjin Pharm. For live market cap and broader valuation context, see Samjin Pharm market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | ₩19.21 Billion | ₩38.15 Billion | ₩18.34 Billion | ▼ -89.2% |
| 2023 | 4.68x | ₩38.97 Billion | ₩8.33 Billion | ₩20.72 Billion | ▼ -23.4% |
| 2022 | 6.10x | ₩105.56 Billion | ₩17.29 Billion | ₩35.50 Billion | ▲ +0.1% |
| 2021 | 6.10x | ₩146.16 Billion | ₩23.97 Billion | ₩74.60 Billion | ▲ +131.8% |
| 2020 | 2.63x | ₩62.78 Billion | ₩23.86 Billion | ₩30.60 Billion | ▲ +160.9% |
| 2019 | 1.01x | ₩23.83 Billion | ₩23.63 Billion | ₩12.04 Billion | ▲ +104.0% |
| 2018 | 0.49x | ₩14.87 Billion | ₩30.08 Billion | ₩8.24 Billion | ▲ +102.7% |
| 2017 | 0.24x | ₩9.09 Billion | ₩37.28 Billion | ₩8.86 Billion | ▲ +13.7% |
| 2016 | 0.21x | ₩10.43 Billion | ₩48.66 Billion | ₩7.80 Billion | ▼ -55.7% |
| 2015 | 0.48x | ₩9.16 Billion | ₩18.94 Billion | ₩7.66 Billion | ▲ +6.4% |
| 2014 | 0.45x | ₩14.74 Billion | ₩32.41 Billion | ₩13.35 Billion | ▼ -61.5% |
| 2013 | 1.18x | ₩8.70 Billion | ₩7.37 Billion | ₩6.83 Billion | — |